Accrued Expenses and Other Current Liabilities (Details) - USD ($) |
Dec. 31, 2015 |
Dec. 31, 2014 |
|---|---|---|
| Accrued Expenses and Other Current Liabilities | ||
| Compensation and benefits | $ 2,599,565 | $ 1,628,102 |
| Clinical trial expenses | 401,029 | 846,199 |
| Other research and development expenses | 96,088 | |
| Other accrued expenses and other current liabilities | 29,188 | 7,880 |
| Total accrued expenses and other current liabilities | $ 3,029,782 | $ 2,578,269 |
| X | ||||||||||
- Definition Represents the amount of clinical trial fees which are due within one year or within the normal operating cycle if longer. No definition available.
|
| X | ||||||||||
- Definition Represents the aggregate amount of accrued expenses and other liabilities not separately disclosed in the balance sheet, which are due within one year or within the normal operating cycle if longer. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of other accrued expenses and other liabilities which are due within one year or within the normal operating cycle if longer. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of other accrued research and development expenses which are due within one year or within the normal operating cycle if longer. No definition available.
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|